Cargando…
Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol
BACKGROUND: Pneumonia is the leading infectious cause of death in children under 5 years of age around the globe. In addition to preventing pneumonia, there is a critical need to provide greater access to appropriate and effective treatment. Studies in Asia have evaluated the effectiveness of 3 days...
Autores principales: | Ginsburg, Amy Sarah, May, Susanne J., Nkwopara, Evangelyn, Ambler, Gwen, McCollum, Eric D., Mvalo, Tisungane, Phiri, Ajib, Lufesi, Norman, Sadruddin, Salim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151015/ https://www.ncbi.nlm.nih.gov/pubmed/30241517 http://dx.doi.org/10.1186/s12879-018-3379-z |
Ejemplares similares
-
Amoxicillin 3 vs 5 days for chest-indrawing pneumonia in Malawian
children
por: Ginsburg, Amy Sarah, et al.
Publicado: (2020) -
Clinical Outcomes of Pneumonia and Other Comorbidities in Children Aged 2-59 Months in Lilongwe, Malawi: Protocol for the Prospective Observational Study “Innovative Treatments in Pneumonia”
por: Ginsburg, Amy Sarah, et al.
Publicado: (2019) -
Title Correction: Clinical Outcomes of Pneumonia and Other Comorbidities in Children Aged 2-59 Months in Lilongwe, Malawi: Protocol for the Prospective Observational Study “Innovative Treatments in Pneumonia”
por: Ginsburg, Amy Sarah, et al.
Publicado: (2019) -
Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial
por: Ginsburg, Amy Sarah, et al.
Publicado: (2018) -
Analysis of serious adverse events in a paediatric fast breathing pneumonia clinical trial in Malawi
por: Nkwopara, Evangelyn, et al.
Publicado: (2019)